Darrell Taylor - 28 Feb 2022 Form 4 Insider Report for BIOCEPT INC

Role
Sr. V.P., General Counsel
Signature
/s/ Darrell Taylor
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
16 Mar 2022, 15:19:23 UTC
Previous filing
16 Mar 2022
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Stock Option (right to buy) Award $0 +134,550 $0.000000 134,550 28 Feb 2022 Common Stock 134,550 $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on the first anniversary of December 28, 2021 with the balance vesting in equal monthly installments thereafter until fully vested on December 28, 2025.